Erratum: tipifarnib in head and neck squamous cell carcinoma with HRAS mutations (J Clin Oncol (2021) DOI: 10.1200/JCO.20.02903)

Allan L. Ho; Irene Brana; Robert Haddad; Jessica Bauman; Keith Bible; Sjoukje Oosting; Deborah J. Wong; Myung Ju Ahn; Valentina Boni; Caroline Even; Jerome Fayette; Maria José Flor; Kevin Harrington; Sung Bae Kim; Lisa Licitra; Ioanna Nixon; Nabil F. Saba; Stephan Hackenberg; Pol Specenier; Francis Worden; Binaifer Balsara; Mollie Leoni; Bridget Martell; Catherine Scholz; Antonio Gualberto

doi:10.1200/JCO.21.02057

Erratum: tipifarnib in head and neck squamous cell carcinoma with HRAS mutations (J Clin Oncol (2021) DOI: 10.1200/JCO.20.02903)

Allan L. Ho, Irene Brana, Robert Haddad, Jessica Bauman, Keith Bible, Sjoukje Oosting, Deborah J. Wong, Myung Ju Ahn, Valentina Boni, Caroline Even, Jerome Fayette, Maria José Flor, Kevin Harrington, Sung Bae Kim, Lisa Licitra, Ioanna Nixon, Nabil F. Saba, Stephan Hackenberg, Pol Specenier, Francis WordenBinaifer Balsara, Mollie Leoni, Bridget Martell, Catherine Scholz, Antonio Gualberto

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

David S. Hong should have appeared in the AUTHORS' DISCLOSURES OF POTENTIAL CONFLICT OF INTEREST list as follows: David S. Hong Stock and Other Ownership Interests: OncoResponse, Telperian.

Original language	English
Pages (from-to)	3192-3193
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	39
Issue number	28
Early online date	28 Sept 2021
DOIs	https://doi.org/10.1200/JCO.21.02057
Publication status	Published - 1 Oct 2021

Keywords

erratum
tipifarnib
head and neck squamos cell carcinoma
HRAS mutations

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.21.02057

Cite this

Ho, A. L., Brana, I., Haddad, R., Bauman, J., Bible, K., Oosting, S., Wong, D. J., Ahn, M. J., Boni, V., Even, C., Fayette, J., Flor, M. J., Harrington, K., Kim, S. B., Licitra, L., Nixon, I., Saba, N. F., Hackenberg, S., Specenier, P., ... Gualberto, A. (2021). Erratum: tipifarnib in head and neck squamous cell carcinoma with HRAS mutations (J Clin Oncol (2021) DOI: 10.1200/JCO.20.02903). Journal of Clinical Oncology, 39(28), 3192-3193. https://doi.org/10.1200/JCO.21.02057

@article{3519546ec6654246b1d5a5362e13dc3b,

title = "Erratum: tipifarnib in head and neck squamous cell carcinoma with HRAS mutations (J Clin Oncol (2021) DOI: 10.1200/JCO.20.02903)",

abstract = "David S. Hong should have appeared in the AUTHORS' DISCLOSURES OF POTENTIAL CONFLICT OF INTEREST list as follows: David S. Hong Stock and Other Ownership Interests: OncoResponse, Telperian.",

keywords = "erratum, tipifarnib, head and neck squamos cell carcinoma, HRAS mutations",

author = "Ho, {Allan L.} and Irene Brana and Robert Haddad and Jessica Bauman and Keith Bible and Sjoukje Oosting and Wong, {Deborah J.} and Ahn, {Myung Ju} and Valentina Boni and Caroline Even and Jerome Fayette and Flor, {Maria Jos{\'e}} and Kevin Harrington and Kim, {Sung Bae} and Lisa Licitra and Ioanna Nixon and Saba, {Nabil F.} and Stephan Hackenberg and Pol Specenier and Francis Worden and Binaifer Balsara and Mollie Leoni and Bridget Martell and Catherine Scholz and Antonio Gualberto",

year = "2021",

month = oct,

day = "1",

doi = "10.1200/JCO.21.02057",

language = "English",

volume = "39",

pages = "3192--3193",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

number = "28",

}

Ho, AL, Brana, I, Haddad, R, Bauman, J, Bible, K, Oosting, S, Wong, DJ, Ahn, MJ, Boni, V, Even, C, Fayette, J, Flor, MJ, Harrington, K, Kim, SB, Licitra, L, Nixon, I, Saba, NF, Hackenberg, S, Specenier, P, Worden, F, Balsara, B, Leoni, M, Martell, B, Scholz, C & Gualberto, A 2021, 'Erratum: tipifarnib in head and neck squamous cell carcinoma with HRAS mutations (J Clin Oncol (2021) DOI: 10.1200/JCO.20.02903)', Journal of Clinical Oncology, vol. 39, no. 28, pp. 3192-3193. https://doi.org/10.1200/JCO.21.02057

TY - JOUR

T1 - Erratum

T2 - tipifarnib in head and neck squamous cell carcinoma with HRAS mutations (J Clin Oncol (2021) DOI: 10.1200/JCO.20.02903)

AU - Ho, Allan L.

AU - Brana, Irene

AU - Haddad, Robert

AU - Bauman, Jessica

AU - Bible, Keith

AU - Oosting, Sjoukje

AU - Wong, Deborah J.

AU - Ahn, Myung Ju

AU - Boni, Valentina

AU - Even, Caroline

AU - Fayette, Jerome

AU - Flor, Maria José

AU - Harrington, Kevin

AU - Kim, Sung Bae

AU - Licitra, Lisa

AU - Nixon, Ioanna

AU - Saba, Nabil F.

AU - Hackenberg, Stephan

AU - Specenier, Pol

AU - Worden, Francis

AU - Balsara, Binaifer

AU - Leoni, Mollie

AU - Martell, Bridget

AU - Scholz, Catherine

AU - Gualberto, Antonio

PY - 2021/10/1

Y1 - 2021/10/1

N2 - David S. Hong should have appeared in the AUTHORS' DISCLOSURES OF POTENTIAL CONFLICT OF INTEREST list as follows: David S. Hong Stock and Other Ownership Interests: OncoResponse, Telperian.

AB - David S. Hong should have appeared in the AUTHORS' DISCLOSURES OF POTENTIAL CONFLICT OF INTEREST list as follows: David S. Hong Stock and Other Ownership Interests: OncoResponse, Telperian.

KW - erratum

KW - tipifarnib

KW - head and neck squamos cell carcinoma

KW - HRAS mutations

UR - https://doi.org/10.1200/JCO.20.02903

U2 - 10.1200/JCO.21.02057

DO - 10.1200/JCO.21.02057

M3 - Comment/debate

AN - SCOPUS:85118944468

SN - 0732-183X

VL - 39

SP - 3192

EP - 3193

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 28

ER -

Erratum: tipifarnib in head and neck squamous cell carcinoma with HRAS mutations (J Clin Oncol (2021) DOI: 10.1200/JCO.20.02903)

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Tipifarnib in head and neck squamous cell carcinoma with HRAS mutations

Cite this